HEADER OXYGEN TRANSPORT 02-JUN-82 1HBS TITLE REFINED CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S. I. RESTRAINED LEAST- TITLE 2 SQUARES REFINEMENT AT 3.0-ANGSTROMS RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN S (DEOXY) (ALPHA CHAIN); COMPND 3 CHAIN: A, C, E, G; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEMOGLOBIN S (DEOXY) (BETA CHAIN); COMPND 7 CHAIN: B, D, F, H; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR E.A.PADLAN,W.E.LOVE REVDAT 7 07-FEB-24 1HBS 1 REMARK SEQADV REVDAT 6 24-FEB-09 1HBS 1 VERSN REVDAT 5 01-APR-03 1HBS 1 JRNL REVDAT 4 29-OCT-85 1HBS 1 JRNL REMARK REVDAT 3 31-JAN-84 1HBS 1 REMARK REVDAT 2 30-SEP-83 1HBS 1 REVDAT REVDAT 1 29-JUL-82 1HBS 0 JRNL AUTH E.A.PADLAN,W.E.LOVE JRNL TITL REFINED CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S. I. JRNL TITL 2 RESTRAINED LEAST-SQUARES REFINEMENT AT 3.0-A RESOLUTION. JRNL REF J.BIOL.CHEM. V. 260 8272 1985 JRNL REFN ISSN 0021-9258 JRNL PMID 4008491 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.A.PADLAN,W.E.LOVE REMARK 1 TITL REFINED CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S. II. REMARK 1 TITL 2 MOLECULAR INTERACTIONS IN THE CRYSTAL REMARK 1 REF J.BIOL.CHEM. V. 260 8280 1985 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH W.E.LOVE,P.M.D.FITZGERALD,J.C.HANSON,W.E.ROYERJUNIOR REMARK 1 TITL INTERMOLECULAR INTERACTIONS IN CRYSTALS OF HUMAN DEOXY REMARK 1 TITL 2 HEMOGLOBIN A, C, F AND S REMARK 1 REF INSERM SYMP. V. 9 65 1978 REMARK 1 REFN ISSN 0378-0546 REMARK 1 REFERENCE 3 REMARK 1 AUTH B.C.WISHNER,J.C.HANSON,W.M.RINGLE,W.E.LOVE REMARK 1 TITL CRYSTAL STRUCTURE OF SICKLE-CELL DEOXYHEMOGLOBIN REMARK 1 EDIT J.I.HERCULES, G.L.COTTAM, M.R.WATERMAN, A.N.SCHECHTER REMARK 1 REF MOLECULAR STRUCTURE AND 1 1976 REMARK 1 REF 2 BIOLOGICAL ACTIVITY REMARK 1 PUBL U.S.DEPT.HEW,BETHESDA,MD.(NIH 76-1007) REMARK 1 REFN REMARK 1 REFERENCE 4 REMARK 1 AUTH B.C.WISHNER,K.B.WARD,E.E.LATTMAN,W.E.LOVE REMARK 1 TITL CRYSTAL STRUCTURE OF SICKLE-CELL DEOXYHEMOGLOBIN AT 5 REMARK 1 TITL 2 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 98 179 1975 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH B.C.WISHNER,W.E.LOVE REMARK 1 TITL CRYSTALS OF DEOXY SICKLE CELL HEMOGLOBIN REMARK 1 EDIT J.I.HERCULES, A.N.SCHECHTER, W.A.EATON, R.E.JACKSON REMARK 1 REF PROCEEDINGS OF THE FIRST 85 1975 REMARK 1 REF 2 NATIONAL SYMPOSIUM ON SICKLE REMARK 1 REF 3 CELL DISEASE REMARK 1 PUBL U.S.DEPT.HEW,BETHESDA,MD.(NIH 75-723) REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8760 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 344 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HBS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173762. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 92.83000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO DEOXY HEMOGLOBIN TETRAMERS IN THE ASYMMETRIC REMARK 300 UNIT. CHAINS A, B, C, D CONSTITUTE THE FIRST TETRAMER AND REMARK 300 CHAINS E, F, G, H CONSTITUTE THE SECOND. THESE TETRAMERS REMARK 300 ARE RELATED APPROXIMATELY BY A NON-CRYSTALLOGRAPHIC REMARK 300 TWO-FOLD SCREW AXIS PARALLEL TO THE A-AXIS OF THE CRYSTAL. REMARK 300 APPLYING THE TRANSFORMATION GIVEN IN THE *MTRIX* RECORDS REMARK 300 BELOW TO THE SECOND TETRAMER WILL YIELD APPROXIMATE REMARK 300 COORDINATES FOR THE FIRST TETRAMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -105.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -101.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 142 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 HEM A 142 NA 93.6 REMARK 620 3 HEM A 142 NB 95.6 88.6 REMARK 620 4 HEM A 142 NC 112.2 153.7 84.0 REMARK 620 5 HEM A 142 ND 109.8 87.6 154.5 88.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 147 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 147 NA 119.7 REMARK 620 3 HEM B 147 NB 95.5 84.2 REMARK 620 4 HEM B 147 NC 105.3 133.5 80.2 REMARK 620 5 HEM B 147 ND 124.7 90.3 135.5 72.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 142 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 87 NE2 REMARK 620 2 HEM C 142 NA 80.1 REMARK 620 3 HEM C 142 NB 104.9 88.4 REMARK 620 4 HEM C 142 NC 124.4 155.5 86.7 REMARK 620 5 HEM C 142 ND 101.1 89.8 153.2 83.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 147 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 147 NA 107.8 REMARK 620 3 HEM D 147 NB 115.6 84.7 REMARK 620 4 HEM D 147 NC 107.8 144.0 84.8 REMARK 620 5 HEM D 147 ND 98.5 85.3 145.9 84.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM E 142 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS E 87 NE2 REMARK 620 2 HEM E 142 NA 75.3 REMARK 620 3 HEM E 142 NB 91.9 82.8 REMARK 620 4 HEM E 142 NC 127.4 157.3 96.1 REMARK 620 5 HEM E 142 ND 99.8 79.6 155.6 93.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM F 147 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS F 92 NE2 REMARK 620 2 HEM F 147 NA 107.0 REMARK 620 3 HEM F 147 NB 99.4 86.5 REMARK 620 4 HEM F 147 NC 89.5 163.3 88.3 REMARK 620 5 HEM F 147 ND 100.6 91.0 159.7 88.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM C 142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM E 142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM F 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM G 142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM H 147 DBREF 1HBS A 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1HBS B 1 146 UNP P68871 HBB_HUMAN 1 146 DBREF 1HBS C 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1HBS D 1 146 UNP P68871 HBB_HUMAN 1 146 DBREF 1HBS E 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1HBS F 1 146 UNP P68871 HBB_HUMAN 1 146 DBREF 1HBS G 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1HBS H 1 146 UNP P68871 HBB_HUMAN 1 146 SEQADV 1HBS VAL B 6 UNP P68871 GLU 6 CONFLICT SEQADV 1HBS VAL D 6 UNP P68871 GLU 6 CONFLICT SEQADV 1HBS VAL F 6 UNP P68871 GLU 6 CONFLICT SEQADV 1HBS VAL H 6 UNP P68871 GLU 6 CONFLICT SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 VAL HIS LEU THR PRO VAL GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 VAL HIS LEU THR PRO VAL GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS SEQRES 1 E 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 E 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 E 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 E 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 E 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 E 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 E 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 E 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 E 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 E 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 E 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 F 146 VAL HIS LEU THR PRO VAL GLU LYS SER ALA VAL THR ALA SEQRES 2 F 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 F 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 F 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 F 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 F 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 F 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 F 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 F 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 F 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 F 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 F 146 LYS TYR HIS SEQRES 1 G 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 G 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 G 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 G 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 G 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 G 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 G 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 G 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 G 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 G 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 G 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 H 146 VAL HIS LEU THR PRO VAL GLU LYS SER ALA VAL THR ALA SEQRES 2 H 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 H 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 H 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 H 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 H 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 H 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 H 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 H 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 H 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 H 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 H 146 LYS TYR HIS HET HEM A 142 43 HET HEM B 147 43 HET HEM C 142 43 HET HEM D 147 43 HET HEM E 142 43 HET HEM F 147 43 HET HEM G 142 43 HET HEM H 147 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 9 HEM 8(C34 H32 FE N4 O4) HELIX 1 AA SER A 3 GLY A 18 1 16 HELIX 2 AB HIS A 20 SER A 35 1 16 HELIX 3 AC PHE A 36 TYR A 42 1 7 HELIX 4 AD HIS A 50 GLY A 51 1DEGEN 2 RES HLX RETAIN HOMOL 2 HELIX 5 AE SER A 52 ALA A 71 1 20 HELIX 6 AF LEU A 80 ALA A 88 1 9 HELIX 7 AG ASP A 94 HIS A 112 1 19 HELIX 8 AH THR A 118 SER A 138 1 21 HELIX 9 BA THR B 4 VAL B 18 1 15 HELIX 10 BB ASN B 19 VAL B 34 1 16 HELIX 11 BC TYR B 35 PHE B 41 1 7 HELIX 12 BD THR B 50 GLY B 56 1 7 HELIX 13 BE ASN B 57 ALA B 76 1 20 HELIX 14 BF PHE B 85 CYS B 93 1 9 HELIX 15 BG ASP B 99 HIS B 117 1 19 HELIX 16 BH THR B 123 HIS B 143 1 21 HELIX 17 CA SER C 3 GLY C 18 1 16 HELIX 18 CB HIS C 20 SER C 35 1 16 HELIX 19 CC PHE C 36 TYR C 42 1 7 HELIX 20 CD HIS C 50 GLY C 51 1DEGEN 2 RES HLX RETAIN HOMOL 2 HELIX 21 CE SER C 52 ALA C 71 1 20 HELIX 22 CF LEU C 80 ALA C 88 1 9 HELIX 23 CG ASP C 94 HIS C 112 1 19 HELIX 24 CH THR C 118 SER C 138 1 21 HELIX 25 DA THR D 4 VAL D 18 1 15 HELIX 26 DB ASN D 19 VAL D 34 1 16 HELIX 27 DC TYR D 35 PHE D 41 1 7 HELIX 28 DD THR D 50 GLY D 56 1 7 HELIX 29 DE ASN D 57 ALA D 76 1 20 HELIX 30 DF PHE D 85 CYS D 93 1 9 HELIX 31 DG ASP D 99 HIS D 117 1 19 HELIX 32 DH THR D 123 HIS D 143 1 21 HELIX 33 EA SER E 3 GLY E 18 1 16 HELIX 34 EB HIS E 20 SER E 35 1 16 HELIX 35 EC PHE E 36 TYR E 42 1 7 HELIX 36 ED HIS E 50 GLY E 51 1DEGEN 2 RES HLX RETAIN HOMOL 2 HELIX 37 EE SER E 52 ALA E 71 1 20 HELIX 38 EF LEU E 80 ALA E 88 1 9 HELIX 39 EG ASP E 94 HIS E 112 1 19 HELIX 40 EH THR E 118 SER E 138 1 21 HELIX 41 FA THR F 4 VAL F 18 1 15 HELIX 42 FB ASN F 19 VAL F 34 1 16 HELIX 43 FC TYR F 35 PHE F 41 1 7 HELIX 44 FD THR F 50 GLY F 56 1 7 HELIX 45 FE ASN F 57 ALA F 76 1 20 HELIX 46 FF PHE F 85 CYS F 93 1 9 HELIX 47 FG ASP F 99 HIS F 117 1 19 HELIX 48 FH THR F 123 HIS F 143 1 21 HELIX 49 GA SER G 3 GLY G 18 1 16 HELIX 50 GB HIS G 20 SER G 35 1 16 HELIX 51 GC PHE G 36 TYR G 42 1 7 HELIX 52 GD HIS G 50 GLY G 51 1DEGEN 2 RES HLX RETAIN HOMOL 2 HELIX 53 GE SER G 52 ALA G 71 1 20 HELIX 54 GF LEU G 80 ALA G 88 1 9 HELIX 55 GG ASP G 94 HIS G 112 1 19 HELIX 56 GH THR G 118 SER G 138 1 21 HELIX 57 HA THR H 4 VAL H 18 1 15 HELIX 58 HB ASN H 19 VAL H 34 1 16 HELIX 59 HC TYR H 35 PHE H 41 1 7 HELIX 60 HD THR H 50 GLY H 56 1 7 HELIX 61 HE ASN H 57 ALA H 76 1 20 HELIX 62 HF PHE H 85 CYS H 93 1 9 HELIX 63 HG ASP H 99 HIS H 117 1 19 HELIX 64 HH THR H 123 HIS H 143 1 21 LINK NE2 HIS A 87 FE HEM A 142 1555 1555 2.39 LINK NE2 HIS B 92 FE HEM B 147 1555 1555 1.96 LINK NE2 HIS C 87 FE HEM C 142 1555 1555 2.50 LINK NE2 HIS D 92 FE HEM D 147 1555 1555 2.07 LINK NE2 HIS E 87 FE HEM E 142 1555 1555 2.59 LINK NE2 HIS F 92 FE HEM F 147 1555 1555 2.59 SITE 1 AC1 10 TYR A 42 PHE A 43 PHE A 46 VAL A 62 SITE 2 AC1 10 LEU A 83 HIS A 87 VAL A 93 ASN A 97 SITE 3 AC1 10 PHE A 98 LEU A 101 SITE 1 AC2 12 PHE B 41 PHE B 42 HIS B 63 ALA B 70 SITE 2 AC2 12 HIS B 92 LEU B 96 VAL B 98 ASN B 102 SITE 3 AC2 12 PHE B 103 LEU B 106 LEU B 141 SER H 9 SITE 1 AC3 9 PHE C 46 LEU C 83 LEU C 86 HIS C 87 SITE 2 AC3 9 LEU C 91 VAL C 93 ASN C 97 PHE C 98 SITE 3 AC3 9 LYS F 59 SITE 1 AC4 11 ASN C 78 LEU D 31 PHE D 41 HIS D 63 SITE 2 AC4 11 VAL D 67 ALA D 70 LEU D 88 HIS D 92 SITE 3 AC4 11 LEU D 96 ASN D 102 LEU D 106 SITE 1 AC5 15 TYR E 42 PHE E 43 HIS E 58 LYS E 61 SITE 2 AC5 15 VAL E 62 ALA E 65 LEU E 66 LEU E 83 SITE 3 AC5 15 HIS E 87 LEU E 91 VAL E 93 ASN E 97 SITE 4 AC5 15 PHE E 98 VAL E 132 LEU E 136 SITE 1 AC6 13 PRO D 5 SER D 9 PHE F 41 PHE F 42 SITE 2 AC6 13 HIS F 63 VAL F 67 LEU F 88 HIS F 92 SITE 3 AC6 13 LEU F 96 ASN F 102 PHE F 103 LEU F 106 SITE 4 AC6 13 LEU F 141 SITE 1 AC7 13 TYR G 42 PHE G 43 HIS G 45 PHE G 46 SITE 2 AC7 13 HIS G 58 LYS G 61 ALA G 65 LEU G 83 SITE 3 AC7 13 LEU G 86 HIS G 87 LEU G 91 VAL G 93 SITE 4 AC7 13 ASN G 97 SITE 1 AC8 10 PHE H 41 HIS H 63 VAL H 67 ALA H 70 SITE 2 AC8 10 LEU H 88 HIS H 92 LEU H 96 ASN H 102 SITE 3 AC8 10 PHE H 103 LEU H 106 CRYST1 63.330 185.660 52.970 90.00 92.69 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015790 0.000000 0.000742 0.00000 SCALE2 0.000000 0.005386 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018899 0.00000 MTRIX1 1 0.999700 -0.021100 0.012740 -31.14513 1 MTRIX2 1 -0.021010 -0.999750 -0.007260 95.20869 1 MTRIX3 1 0.012890 0.006990 -0.999890 79.04881 1